2005
DOI: 10.1053/j.ajkd.2005.04.031
|View full text |Cite
|
Sign up to set email alerts
|

Left Ventricular Hypertrophy in Nondiabetic Predialysis CKD

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

9
143
4
7

Year Published

2008
2008
2023
2023

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 186 publications
(163 citation statements)
references
References 30 publications
9
143
4
7
Order By: Relevance
“…This is mainly due to the multifactorial pathogenesis of LVH in renal patients, in whom both hemodynamic and non-hemodynamic stimuli act synergically to induce either an increase in left ventricular mass or an LV dilation. Anemia and arterial hypertension seem to be the most important factors in this process (28). Interventional studies have shown that partial correction of anemia through epoetin, together with a successful arterial hypertension therapy using ACE inhibitors or other drugs acting on the RAS, can induce LVH regression in CKD.…”
Section: Discussionmentioning
confidence: 99%
“…This is mainly due to the multifactorial pathogenesis of LVH in renal patients, in whom both hemodynamic and non-hemodynamic stimuli act synergically to induce either an increase in left ventricular mass or an LV dilation. Anemia and arterial hypertension seem to be the most important factors in this process (28). Interventional studies have shown that partial correction of anemia through epoetin, together with a successful arterial hypertension therapy using ACE inhibitors or other drugs acting on the RAS, can induce LVH regression in CKD.…”
Section: Discussionmentioning
confidence: 99%
“…[8,9] Previous studies have evaluated the association of kidney function with LVH in patients with advanced disease approaching and requiring dialysis [10,11] as well as patients with earlier stages of disease [8]; LVH has been reported in over one-third of persons with CKD. [9] Diastolic dysfunction has also been studied in small cohorts of CKD patients.…”
Section: Introductionmentioning
confidence: 99%
“…Left ventricular hypertrophy (LVH), a frequent expression of subclinical target-organ damage related to hypertension, is a very common structural abnormality in patients with chronic kidney disease (CKD), [1][2][3] and is independently associated with cardiovascular (CV) morbidity and mortality. 4,5 LV diastolic dysfunction is also frequent among CKD patients and is associated with the risk to develop heart failure and with mortality.…”
Section: Introductionmentioning
confidence: 99%